NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i

BTIG analyst Marie Thibault reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy and maintains $1

Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold,

iRhythm says hackers stole patient and proprietary data from third-party apps but sees no material i

Material Cybersecurity Incidents. On June 8, 2026, iRhythm Holdings, Inc. (the "Company") id

BTIG analyst Marie Thibault reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy and maintains $1

On June 3, 2026, iRhythm Technologies, Inc. ("iRhythm Tech"), a wholly owned subsidiary of i

Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy an

B of A Securities analyst Stephanie Piazzola maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy

Citigroup analyst Joanne Wuensch maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises t

Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy an

JP Morgan analyst Allen Gong maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lower

Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight an

Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform

Needham analyst David Saxon maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the pr

iRhythm Holdings (NASDAQ:IRTC) raises FY2026 sales outlook from $870.000 million-$880.000 million to

iRhythm Technologies (NASDAQ:IRTC) reported quarterly losses of $(0.35) per share which beat the ana

Truist Securities analyst Richard Newitter maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy an

Goldman Sachs analyst David Roman maintains iRhythm Holdings (NASDAQ:IRTC) with a Neutral and low

Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform

Citigroup analyst Joanne Wuensch maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers t

Truist Securities analyst Richard Newitter reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy a

Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy an

JP Morgan analyst Allen Gong maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lower

Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight an

Baird analyst Mike Polark maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and lowers t

iRhythm Holdings (NASDAQ:IRTC) affirms FY2026 sales outlook from $870.000 million-$880.000 million t

iRhythm Technologies (NASDAQ:IRTC) reported quarterly earnings of $0.29 per share which beat the ana

iRhythm shares slid after a Zio MCT delay, but William Blair says the selloff is overdone and keeps

Wells Fargo analyst Nathan Treybeck maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweigh

Needham analyst David Saxon reiterates iRhythm Technologies (NASDAQ:IRTC) with a Buy and maintain

iRhythm Technologies (NASDAQ:IRTC) sees FY2026 sales of $870.000 million-$880.000 million vs $862.68

iRhythm Technologies (NASDAQ:IRTC) raises FY2025 sales outlook from $735.000 million-$740.000 millio

Recent Operational Highlights and Financial OutlookAnticipate full year 2025 revenue to exceed high

Evercore ISI Group analyst Vijay Kumar upgrades iRhythm Technologies (NASDAQ:IRTC) from In-Line t

Truist Securities analyst Richard Newitter maintains iRhythm Technologies (NASDAQ:IRTC) with a Bu

Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overwe

iRhythm Technologies presented new data during the joint Asia Pacific Heart Rhythm Society (APHRS) a

Real-world data across more than 1 million patients published in Heart Rhythm show that 24–48-hour m

Canaccord Genuity analyst William Plovanic maintains iRhythm Technologies (NASDAQ:IRTC) with a Bu

Citigroup analyst Joanne Wuensch maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and rais

JP Morgan analyst Allen Gong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and r

iRhythm Technologies beat Q3 estimates with record revenue, raised its 2025 sales outlook, and gaine